Newsfeeds - Spark Newswire

1 minute read

Earnings

Earnings Preview: ViewRay

Today, 2:04 AM

ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that ViewRay will report an earnings per share (EPS) of $-0.16.

VRAY

1 minute read

ViewRay’s MRIdian MRI-Guided Imaging System Signal Superiority For Localized Prostate Cancer

By Vandana Singh

Today, 2:04 AM

ViewRay Inc (NASDAQ: VRAY) has

VRAY

4 minute read

ViewRay Announces Interim Data From MIRAGE Phase III Randomized Trial

By Bill Haddad

Today, 2:04 AM

Poster on Interim Trial Data Comparing MRI-Guided vs. CT-Guided SBRT Toxicities for Prostate Cancer to be Featured at American Society of Clinical Oncology GU Cancers Symposium CLEVELAND, Feb. 15, 2022 /PRNewswire/ --

VRAY

1 minute read

Stifel Initiates Coverage On ViewRay with Buy Rating, Announces Price Target of $7

By Benzinga Newsdesk

Today, 2:04 AM

Stifel analyst Rick Wise initiates coverage on ViewRay (NASDAQ:VRAY) with a Buy rating and announces Price Target of $7.

VRAY

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 11, 2022

By Benzinga Insights

Today, 2:04 AM

2 minute read

ViewRay Sees Prelim. FY21 Revenue ~$70M vs $69.69M Est.

By Bill Haddad

Today, 2:04 AM

ViewRay, Inc. (NASDAQ:VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended December 31, 2021. The preliminary results have not been audited

VRAY

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 2:04 AM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

1 minute read

Earnings

ViewRay’s Earnings: A Preview

By Benzinga Insights

Today, 2:04 AM

ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Thursday, 2021-11-04. Here's what investors need to know before the announcement. Analysts estimate that ViewRay will likely report an Earnings Per Share (EPS) of $-0.16

VRAY

3 minute read

News

ViewRay Announces New Outcomes Data Demonstrating Prolonged Survival For Inoperable Pancreatic Cancer Patients Presented At Leading Radiation Oncology Meeting

By Benzinga Newsdesk

Today, 2:04 AM

ViewRay, Inc. (NASDAQ:VRAY) today announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with MRIdian SMART (MR-guided stereotactic adaptive radiation therapy) were

VRAY

1 minute read

Helsinki University Hospital Purchases A MRIdian System For Installation At Comprehensive Cancer Center; Financial Terms Not Disclosed

By Bill Haddad

Today, 2:04 AM

ViewRay, Inc. (NASDAQ:VRAY) today announced that Helsinki University Hospital has purchased a MRIdian® System to offer patients MR-guided radiation therapy at the Comprehensive Cancer Center in the new

VRAY